Adjuvant chemotherapy of post-surgical minimal residual bronchial carcinomas.

Adjuvant chemotherapy of post-surgical minimal residual bronchial carcinomas. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Adjuvant chemotherapy of post-surgical minimal residual bronchial carcinomas. Abstract Text:

K Karrer,

Adjuvant chemotherapy of post-surgical minimal residual bronchial carcinomas. Publishing Authors By Initials

K Karrer,

For similar neoplasms: neoplastic processes: neoplasm recurrence, local research abstracts see: neoplasms: neoplastic processes: neoplasm recurrence, local research

PUBMED ID PMID:

MEDLINE DATE:

Adjuvant chemotherapy of post-surgical minimal residual bronchial carcinomas. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Recent results in cancer research. Fortschritte de

VOLUME: 68

Page Numbers: 246-59

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 1978

Adjuvant chemotherapy of post-surgical minimal residual bronchial carcinomas. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 44671

Adjuvant chemotherapy of post-surgical minimal residual bronchial carcinomas. Keywords Mesh Terms:

KEYWORDS: Neoplasm Recurrence, Local

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Adjuvant chemotherapy of post-surgical minimal residual bronchial carcinomas. Information

Substance Name: Antineoplastic Agents

Registry Number: 0

Grant and Affiliation Information for Adjuvant chemotherapy of post-surgical minimal residual bronchial carcinomas.

AFFILIATION:

Country: GERMANY, WEST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Adjuvant chemotherapy of post-surgical minimal residual bronchial carcinomas Related Publications

• Adjuvant chemotherapy of post-surgical minimal residual bronchial carcinomas.
• Diagnostic and prognostic importance of tumor markers in lung cancer.
• Diagnostic and prognostic importance of tumor markers in lung cancer.
• Paul Karrer, 21 April 1889--18 June 1971.
• Relationship of dose schedules to the effectiveness of adjuvant chemotherapy.
• Severe acneiform skin reaction during therapy with erlotinib (Tarceva((R))), an epidermal growth factor receptor (EGFR) inhibitor.
• Smoking habits and epidemiology of lung cancer in Austria.
• Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors.
• Tumor markers for the diagnosis, prognosis, treatment and follow-up of gynaecological tumors.
• [Behaviour of tumor cells in circulating blood of liver sinusoids (author's transl)]
• [Corticosteroid sparing agents for polymyalgia rheumatica and arteritis temporalis (Horton's disease)]
• [Current techniques in pneumonology/pulmonary infections]
• [Further animal studies on the problem of prevention of recurrence of carcinoma.]
• [Mechanical home ventilation: indications for and application of nocturnal ventilation using nasal masks in chronic hypoventilation]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Occupational lung diseases]
• [Results of intravenous implantation of inoculation neoplasms.]
• [Sleep and respiration]
• [Sleep well (about the healthy and deep sleep)]
• [The Steinthal or TNM systems for the classification of breast carcinoma?]
• [The problem of latent tumor cell foci.]
• [The treatment of obstructive sleep apnea]
• [Therapy of keloids.]
• [Therapy-resistant asthma: causes and therapy]